Literature DB >> 4718922

Effect of influenza anti-neuraminidase antibody on virus neutralization.

J A Kasel, R B Couch, J L Gerin, J L Schulman.   

Abstract

Antibody to influenza virus neuraminidase participates in tissue culture neutralization tests in which inhibition of hemadsorption is the end point. Presumably, by inhibiting virus release it functions additively with anti-hemagglutinin in reducing total virus replication.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4718922      PMCID： PMC422821          DOI： 10.1128/iai.8.1.130-131.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  5 in total

1.  Newly recognized myxoviruses from children with respiratory disease.

Authors:  R M CHANOCK; R H PARROTT; K COOK; B E ANDREWS; J A BELL; T REICHELDERFER; A Z KAPIKIAN; F M MASTROTA; R J HUEBNER
Journal:  N Engl J Med       Date:  1958-01-30       Impact factor: 91.245

2.  Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine.

Authors:  E D Kilbourne; J L Schulman; G C Schild; G Schloer; J Swanson; D Bucher
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

3.  Reactions of antibodies with surface antigens of influenza virus.

Authors:  R G Webster; W G Laver; E D Kilbourne
Journal:  J Gen Virol       Date:  1968-12       Impact factor: 3.891

4.  Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus.

Authors:  R G Webster; W G Laver
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

5.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103
  5 in total
  5 in total

Review 1.  Inactivated influenza virus vaccines: the future of TIV and QIV.

Authors:  Michael Schotsaert; Adolfo García-Sastre
Journal:  Curr Opin Virol       Date:  2017-05-12       Impact factor: 7.090

2.  Description of a technique for the analysis of antineuraminidase antibodies oriented to H2N2 and H3N2 influenza virus strains.

Authors:  J Drescher
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.

Authors:  Fu-Shi Quan; Min-Chul Kim; Byeong-Jae Lee; Jae-Min Song; Richard W Compans; Sang-Moo Kang
Journal:  Virology       Date:  2012-06-02       Impact factor: 3.616

Review 4.  Virus-like particles as universal influenza vaccines.

Authors:  Sang-Moo Kang; Min-Chul Kim; Richard W Compans
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

5.  H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines.

Authors:  Sook-San Wong; Jennifer DeBeauchamp; Mark Zanin; Yilun Sun; Li Tang; Richard Webby
Journal:  NPJ Vaccines       Date:  2017-06-08       Impact factor: 7.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.